B42.81 Cerebral sporotrichosis

Name of the Condition

• Cerebral sporotrichosis

Summary

Cerebral sporotrichosis is a rare fungal infection caused by the Sporothrix species, specifically affecting the central nervous system. It occurs when the fungus spreads to the brain or meninges, typically as a complication of disseminated sporotrichosis. The condition is acquired through environmental exposure to fungal spores, with the fungus entering the body via skin breaks and progressing to systemic involvement in immunocompromised individuals.

Causes

Cerebral sporotrichosis is caused by the Sporothrix fungus, which is commonly found in soil, decaying vegetation, and plant matter. Infection occurs when fungal spores enter the body through breaks in the skin or, less commonly, through inhalation. The fungus can then disseminate hematogenously, reaching the central nervous system and causing infection.

Risk Factors

• Weakened immune systems, including those with HIV/AIDS, diabetes, or immunosuppressive therapy.
• Disseminated sporotrichosis, where the infection has spread beyond the initial site.
• Prolonged exposure to environments with high fungal spore concentrations (e.g., gardening, farming).

Symptoms

• Headache, often severe or persistent.
• Altered mental status, confusion, or cognitive changes.
• Fever, neck stiffness, or signs of meningitis.
• Focal neurological deficits, such as weakness or sensory changes.
• Seizures in some cases.

Diagnosis

Diagnosis is typically made through a combination of clinical evaluation, imaging studies (e.g., MRI or CT of the brain), and laboratory testing. Cerebrospinal fluid (CSF) analysis may show elevated white blood cells, protein, or fungal elements. Culture or PCR testing of CSF or tissue samples can confirm the presence of Sporothrix. Biopsy of affected brain tissue may be performed in some cases.

Treatment Options

• Antifungal medications, such as Amphotericin B (initially) followed by Itraconazole or Voriconazole for maintenance.
• Intrathecal or intraventricular antifungal therapy in severe cases.
• Supportive care for neurological symptoms, including anticonvulsants or corticosteroids (if needed).

Prognosis and Follow-Up

Prognosis depends on the severity of infection and the patient’s immune status. Early diagnosis and treatment improve outcomes, but cerebral sporotrichosis can be life-threatening. Follow-up includes monitoring for treatment response, repeat imaging, and CSF analysis. Long-term antifungal therapy may be required, with regular clinical assessments.

Complications

• Permanent neurological damage (e.g., cognitive impairment, motor deficits).
• Meningitis or encephalitis.
• Recurrence of infection if treatment is incomplete.
• Death in severe or untreated cases.

Lifestyle & Prevention

• Avoid contact with soil or plant material that may harbor fungal spores, especially if immunocompromised.
• Wear protective clothing (e.g., gloves, long sleeves) when gardening or handling vegetation.
• Clean skin injuries thoroughly and seek medical care for wounds exposed to potential fungal sources.
• Maintain immune health through proper management of underlying conditions.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, neck stiffness, confusion, or neurological symptoms, especially if there is a history of fungal exposure or immunosuppression.

Tips for Medical Coders

Code B42.81 is specific to cerebral sporotrichosis and should be used when the infection is documented as involving the brain or central nervous system. Ensure documentation supports the site of infection (e.g., "cerebral," "meningeal," or "central nervous system" involvement) to justify the code. Differentiate from other fungal infections or systemic sporotrichosis codes based on the documented location of infection.